Modus Therapeutics Holding AB (publ) (STO:MODTX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.5000
+0.0800 (19.05%)
Apr 24, 2026, 5:29 PM CET
Market Cap60.81M +18.7%
Revenue (ttm)n/a
Net Income-18.54M
EPS-0.30
Shares Out121.63M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,943,856
Average Volume1,369,621
Open0.4220
Previous Close0.4200
Day's Range0.4220 - 0.5140
52-Week Range0.2080 - 5.0000
Beta0.14
RSI75.96
Earnings DateApr 15, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol MODTX
Full Company Profile

Financial Performance

Financial Statements